Higher revenue and gross profit from an increase in HAL installations
First written in FY2017-Q3. 21 of 30 entries say "Advanced", first in FY2017. Latest entry: FY2027-H1.
No other company in this theme has enough history to compare yet.
- FY2027-H1AdvancedAnnual report
「As a result, for the interim consolidated accounting period, revenue totaled ¥2,008 million, up 2.3% year on year, as sales from product rentals and other activities in Japan and APAC, as well as treatment services and other activities in the United States, increased」
Revenue for the interim period totaled ¥2,008 million, up 2.3% year on year, driven by increased sales from product rentals in Japan and APAC and treatment services in the United States, among other activities. - FY2026Decline in revenue due to the sale of LeyLine and other factorsAnnual report
「Revenue was ¥3,846 million, down 12.3% year on year, partly due to the impact of the sale of the German subsidiary LeyLine in the previous fiscal year.」
Revenue decreased 12.3% from ¥4,384 million in the previous year to ¥3,846 million, due in part to the impact of the sale of the German subsidiary LeyLine. - FY2025-H1AdvancedAnnual report
「As a result, revenue for the interim consolidated period was ¥2,143 million, up 1.9% year on year, as medical services revenue in the United States and elsewhere increased, and」
Revenue for the interim period increased 1.9% year on year to ¥2,143 million, reflecting growth in medical services revenue in the United States and elsewhere. - FY2024AdvancedAnnual report
「As a result, revenue for the consolidated fiscal year was ¥4,354 million, up 32.4% year on year, due to growth in rental revenue for HAL and other products supplied overseas and service revenue from the Group's companies in Europe and the United States.」
Revenue increased 32.4% from ¥3,289 million in the previous year to ¥4,354 million, due to rental revenue for HAL and other products supplied overseas and service revenue in Europe and the United States. - FY2024-Q3AdvancedAnnual report
「As a result, revenue for the cumulative consolidated third quarter was ¥3,219 million, up 35.6% year on year, as treatment services revenue in the United States and rental revenue for products supplied overseas and elsewhere increased substantially, and gross profit increased 17.6% to ¥1,742 million.」
Revenue increased 35.6% year on year to ¥3,219 million, driven by growth in treatment services revenue in the United States and rental revenue for products supplied overseas and elsewhere. - FY2024-Q2AdvancedAnnual report
「As a result, revenue for the cumulative consolidated second quarter was ¥2,104 million, up 36.4% year on year, as medical services revenue in the United States and rental revenue from Europe and elsewhere increased substantially, and gross profit increased 15.7% to ¥1,144 million.」
Revenue increased 36.4% year on year to ¥2,104 million, driven by growth in medical services revenue in the United States and rental revenue from Europe and elsewhere, while gross profit also increased to ¥1,144 million. - FY2024-Q1AdvancedAnnual report
「As a result, revenue for the cumulative consolidated first quarter was ¥1,045 million, up 39.1% year on year, as medical services revenue in the United States and rental revenue from Europe and elsewhere increased substantially, and」
Revenue increased 39.1% year on year to ¥1,045 million, driven by growth in medical services revenue in the United States and rental revenue from Europe and elsewhere. - FY2023-Q3AdvancedAnnual report
「As a result, revenue for the cumulative consolidated third quarter was ¥2,374 million, up 76.3% year on year, as medical services revenue in the United States and rental revenue from Asia and Europe increased substantially, and」
Revenue increased 76.3% year on year to ¥2,374 million, driven by substantial growth in medical services revenue in the United States and rental revenue from Asia and Europe. - FY2023-Q2AdvancedAnnual report
「As a result, revenue for the cumulative consolidated second quarter was ¥1,542 million, up 86.9% year on year, as medical services revenue in the United States and rental revenue from Asia and Europe increased substantially, and」
Revenue increased 86.9% year on year to ¥1,542 million, driven by substantial growth in medical services revenue in the United States and rental revenue from Asia and Europe. - FY2023-Q1AdvancedAnnual report
「As a result, revenue for the cumulative first quarter of the current consolidated fiscal year was ¥751 million, up 97.6% year on year, due to significant increases in medical services sales in the United States and rental sales to Asia and Europe.」
Revenue increased 97.6% year on year to ¥751 million, driven by substantial growth in medical services revenue in the United States and rental revenue from Asia and Europe. - FY2022-Q3AdvancedAnnual report
「As a result, revenue for the cumulative first three quarters of the current consolidated fiscal year was ¥1,347 million, up 8.0% year on year, due to growth in overseas sales and the recovery of the RoboCare business and the treatment services business in Germany, among other factors.」
Revenue increased to ¥1,347 million, up 8.0% year on year, due to growth in overseas sales and the recovery of the RoboCare business and the treatment services business in Germany, among other factors, following a decline caused by COVID-19 in the previous fiscal year. - FY2022-Q2AdvancedAnnual report
「As a result, revenue for the cumulative second quarter of the current consolidated fiscal year was ¥825 million, up 3.9% year on year, due to growth in overseas sales and the recovery of the RoboCare business and the treatment services business in Germany, among other factors. Gross profit was ¥619 million, up 12.0% year on year.」
Cumulative revenue was ¥825 million, up 3.9% year on year, due to growth in overseas sales and the recovery of the RoboCare business and the treatment services business in Germany. - FY2022-Q1Revenue growth from recoveryAnnual report
「As a result, revenue for the cumulative first quarter of the current consolidated fiscal year was ¥380 million, up 5.9% year on year, due to the recovery of the RoboCare business and the treatment services business in Germany, among other factors.」
Due to the recovery of the RoboCare business and the treatment services business in Germany, revenue increased 5.9% year on year to ¥380 million, representing a partial recovery from the revenue decline caused by COVID-19. - FY2021-Q3Continued revenue decline due to COVID-19Annual report
「As a result, during the cumulative third quarter of the consolidated fiscal period, revenue was ¥1,247 million, down 1.4% year on year, and gross profit was ¥858 million, down 6.8%. Although sales of goods and products increased, training service revenue and other revenue declined due to the impact of COVID-19.」
Although sales revenue from goods and products, including medical HAL, increased, cumulative revenue declined 1.4% year on year due to lower training service revenue and other revenue. - FY2021-Q2Continued revenue decline due to COVID-19Annual report
「As a result, revenue for the cumulative second quarter of the current consolidated fiscal year was ¥794 million, down 3.5% year on year. Sales of goods and products increased, but this was offset by a decline in training service revenue and other revenue due to the impact of COVID-19.」
Although sales revenue from goods and products, including medical HAL, increased, cumulative revenue declined 3.5% year on year due to lower training service revenue and other revenue. - FY2021-Q1Revenue decline due to the impact of COVID-19Annual report
「Revenue was ¥359 million, down 8.8% year on year. Sales of goods and products increased, but this was offset by a decline in training service revenue and other revenue due to the impact of COVID-19.」
Although sales revenue from goods and products, including medical HAL, increased, first-quarter revenue declined 8.8% year on year due to lower training service revenue and other revenue. - FY2020AdvancedAnnual report
「As a result, revenue for the current consolidated fiscal year was ¥1,792 million, up 4.8% year on year, due mainly to an increase in rental revenue and other revenue, primarily from medical HAL®.」
After revenue declined in the previous fiscal year due to lower one-time sales and other factors, full-year revenue recovered to ¥1,792 million, up 4.8% year on year, driven by an increase in rental revenue and other revenue, mainly from medical HAL. - FY2020-Q3AdvancedAnnual report
「As a result, revenue for the cumulative first three quarters of the current consolidated fiscal year was ¥1,265 million, up 2.5% year on year, due mainly to an increase in rental revenue and other revenue, primarily from medical HAL®.」
Driven by an increase in rental revenue and other revenue, mainly from medical HAL, cumulative revenue for the first three quarters was ¥1,265 million, up 2.5% year on year. Although the year-on-year revenue growth rate declined from the previous disclosure, revenue itself increased. - FY2020-Q2AdvancedAnnual report
「As a result, revenue for the cumulative second quarter of the current consolidated fiscal year was ¥823 million, up 9.5% year on year, due mainly to an increase in rental revenue and other revenue, primarily from medical HAL®.」
Driven by an increase in rental revenue and other revenue, mainly from medical HAL, cumulative revenue was ¥823 million, up 9.5% year on year. - FY2020-Q1AdvancedAnnual report
「As a result, revenue for the cumulative first quarter of the current consolidated fiscal year was ¥393 million, up 17.4% year on year, due mainly to an increase in rental revenue and other revenue, primarily from medical HAL®.」
Revenue, which had declined in the previous year due to the reversal of one-time revenue, increased to ¥393 million, up 17.4% year on year, due to an increase in rental revenue and other revenue, mainly from medical HAL. - FY2019Full-year decline in revenue due to lower one-time sales and other factorsAnnual report
「As a result, revenue for the current consolidated fiscal year was ¥1,709 million, down 1.1% year on year. Rental revenue, mainly from medical HAL®, increased, but this was offset by the impact of lower one-time sales of HAL® for lower-back nursing care support and other products.」
Although rental revenue, mainly from medical HAL, increased, full-year revenue decreased 1.1% year on year due to lower one-time sales of nursing care support products and other items. - FY2019-Q3AdvancedAnnual report
「As a result, revenue for the cumulative first three quarters of the current consolidated fiscal year was ¥1,234 million, up 6.0% year on year, due mainly to an increase in rental revenue and other revenue, primarily from medical HAL®.」
Driven by an increase in rental revenue and other revenue, mainly from medical HAL, cumulative revenue was ¥1,234 million, up 6.0% year on year. - FY2019-Q2Narrower year-on-year decline in revenueAnnual report
「As a result, revenue for the cumulative second quarter of the current consolidated fiscal year was ¥752 million, down 1.3% year on year. Rental revenue and other revenue, mainly from medical HAL®, increased, but this was offset by the impact of one-time revenue in the previous fiscal year.」
Although rental revenue and other revenue, mainly from medical HAL, increased, revenue decreased 1.3% year on year due to the reversal of one-time revenue recorded in the previous fiscal year. The decline narrowed from 5.3% year on year in the first quarter. - FY2019-Q1Decline in revenue year on yearAnnual report
「As a result, revenue for the cumulative first quarter of the current consolidated fiscal year was ¥335 million, down 5.3% year on year. Rental revenue and other revenue increased, mainly from medical HAL®, but this was offset by the impact of one-time revenue in the previous fiscal year.」
Although rental revenue and other revenue, mainly from medical HAL, increased, first-quarter revenue was ¥335 million, down 5.3% year on year, due to the reversal of one-time revenue recorded in the previous fiscal year. - FY2018AdvancedAnnual report
「As a result, revenue for the current consolidated fiscal year was ¥1,728 million, up 4.1% year on year, primarily due to an increase in installations of medical HAL® and HAL® for lower-back support, while gross profit increased to ¥1,204 million, up 12.3% year on year.」
Driven primarily by an increase in installations of medical HAL and HAL for lower-back support, full-year revenue was ¥1,728 million, up 4.1% year on year, and gross profit was ¥1,204 million, up 12.3%. - FY2018-Q3AdvancedAnnual report
「As a result, revenue for the cumulative first three quarters of the current consolidated fiscal year was ¥1,163.539 million, up 10.3% year on year, primarily due to an increase in installations of medical HAL®, while gross profit increased to ¥815.489 million, up 18.4% year on year.」
Driven primarily by an increase in installations of medical HAL, cumulative revenue was ¥1,163.539 million, up 10.3% year on year, and gross profit was ¥815.489 million, up 18.4%. - FY2018-Q2AdvancedAnnual report
「As a result, revenue for the cumulative second quarter of the current consolidated fiscal year was ¥761.095 million, up 26.7% year on year, primarily due to an increase in rentals of medical HAL® and HAL® for lower-back nursing care support, while gross profit increased to ¥525.481 million, up 36.0% year on year.」
Driven by an increase in rentals of medical HAL and HAL for nursing care support, revenue was ¥761.095 million and gross profit was ¥525.481 million. - FY2018-Q1AdvancedAnnual report
「As a result, revenue for the cumulative first quarter of the current consolidated fiscal year was ¥353.176 million, up 29.9% year on year, primarily due to a significant increase in installations of medical HAL® and HAL® for nursing care support (lower-back type), while gross profit increased to ¥242.351 million, up 33.8% year on year.」
Driven by an increase in installations of medical HAL and HAL for nursing care support, quarterly revenue was ¥353.176 million, up 29.9% year on year, and gross profit was ¥242.351 million, up 33.8%. - FY2017AdvancedAnnual report
「As a result, revenue for the current consolidated fiscal year was ¥1,649.940 million, up 30.4% year on year, primarily due to an increase in installations of medical HAL® and HAL® for nursing care support (lower-back type), while gross profit increased to ¥1,078.953 million, up 24.9% year on year.」
Driven by an increase in installations of medical HAL and HAL for nursing care support, full-year revenue was ¥1,649.940 million, up 30.4% year on year. - FY2017-Q3First statedAnnual report
「As a result, revenue for the cumulative first three quarters of the current consolidated fiscal year was ¥1,055.339 million, up 18.6% year on year, primarily due to an increase in installations of medical HAL® and HAL® for nursing care support (lower-back type), while gross profit increased to ¥688.528 million, up 14.0% year on year. Revenue for the third quarter alone increased significantly by 35.8% year on year.」
The Company disclosed as a new performance result that revenue and gross profit increased year on year, driven by an increase in installations of medical HAL and HAL for nursing care support.